Receipt of Observation Letter indicating "No Objection" from National Stock Exchange of India (NSE) in relation to Scheme of Arrangement between Meridian Medical Research & Hospital Ltd ....
Awaiting price reaction for this filing.
The company has received an observation letter from the National Stock Exchange of India (NSE) stating 'no objection' to its proposed Scheme of Arrangement. The full counterparty and structure of the scheme are not visible in the truncated headline, but it involves Meridian Medical Research & Hospital Ltd. This is a procedural regulatory step that typically follows stock exchange approvals and precedes filing with the National Company Law Tribunal (NCLT) for final sanction.
Clears one of the key regulatory hurdles (stock exchange approval) in the scheme approval process. Shareholders should await further updates on NCLT filing, shareholder/court meeting dates, and the final terms (ratio, valuation) of the arrangement. Near-term stock movement is usually limited unless material new terms are disclosed.